Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2015 09:17 ET | Source: Cellular Biomedicine Group Inc.

CBMG Selected for Inclusion in the Russell 3000 Index

SHANGHAI, China and PALO ALTO, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
June 09, 2015 08:30 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Enters Into Definitive Agreement to Acquire CD40LGVAX Vaccine and Related Technologies and Know-How Which Will be Used in a Pending PD-1 Combination Clinical Trial in the U.S. for Non-Small Cell Lung Cancer (NSCLC)

SHANGHAI, China and PALO ALTO, Calif., June 9, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new...
June 05, 2015 08:30 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Announces Publication of Human Adipose-Derived Progenitor Cells to Treat Knee Osteoarthritis

SHANGHAI, China and PALO ALTO, Calif., June 5, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
May 29, 2015 09:00 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group to Provide Business and Clinical Updates at Jefferies 2015 Global Healthcare Conference

SHANGHAI, China and PALO ALTO, Calif., May 29, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
May 27, 2015 08:00 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Expands and Strengthens Leadership Team

PALO ALTO, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...
May 22, 2015 09:17 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Announces Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program

SHANGHAI, China and PALO ALTO, Calif., May 22, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
May 18, 2015 06:10 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Reports First Quarter 2015 Financial Results and Provides Business Highlights

PALO ALTO, Calif., May 18, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group, Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...
May 12, 2015 09:30 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group, Inc. Featured on Wide World of Stocks Television

PALO ALTO, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...
April 30, 2015 18:30 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Responds to Purported Class Action Lawsuit

PALO ALTO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...
April 30, 2015 09:30 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Appoints Two New Members to Scientific Advisory Board

PALO ALTO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective stem cell...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right